Julane Andries LMFT is a practicing psychotherapist in Marin County, Ca. She worked in acute care medicine before becoming a marriage family therapist. She was the principle co-therapist for the MAPS sponsored, MDMA assisted psychotherapy study for individuals suffering from anxiety with life-threatening illness. She is also co-therapist in the new Phase 3 study using MDMA assisted psychotherapy for severe PTSD in San Francisco.
Julane’s work with Ketamine-Assisted Psychotherapy (KAP) is unique and is creative to the psychotherapy process using this medicine. She and Phil Wolfson MD, along with others on their team, treat patients with treatment resistant depression, first line depression, anxiety and PTSD. They have created a therapy using the relaxed trance state that Ketamine induces to provide relief of depressive symptoms, insight into individual processing of core issues and transformation. They also work with the transformative state incurred with IM Ketamine.
She and Dr. Wolfson have recently founded a non-profit, Ketamine Research Foundation, whose mission is to provide training for practitioners, collect data to track outcomes with Ketamine therapy, starting a new protocol for using KAP for those diagnosed with a life threatening illness, and those in palliative and hospice care. The foundation will also provide financial assistance for those who cannot afford Ketamine treatment. Julane is also co-founder of the Ketamine Training Center. She has helped provide trainings for practitioners wanting to learn the art and science of KAP. they have conducted experiential trainings around the country.
Julane has a passionate interest in understanding trauma, its impact on the mind and body, and in stimulating the healing process.
Board officer for Ketamine Research Foundation
Research in outcomes for KAP
Phase 2 and phase 3 –Co-therapist FDA trial for MDMA Assisted Psychotherapy for Severe PTSD
Co-Therapist and co-founder of CTP
Papers and research:
1.MDMA for Anxiety with Life Threatening Illness
2.Outcomes for 3 Practices using KAP
3. Ketamine and Lactation research – pre-publishment
1. Research study using ketamine protocol for end-of-life anxiety
2. Developing a postpartum study after research on levels of ketamine in breast milk in lactating mothers
3. Researching methods using low dose ketamine for anxiety.